Prohost Letter #386
An Evaluation of Prohost Picks
and Some Other Interesting Biotechnology Companies (Part 2)
(Continued from Previous Prohost Letter #385) See Page
Listening to Top-tier biotech firms’ presentations we could not resist appreciating their
accomplishments, which made us dare to predict that the time has come for the self-serving
preachers to find it extremely hard to convince shareholders to to sell stocks of top accomplishing
firms at times when they are undervalued not overvalued . . .